p classMsoNormal styleline-height: 20.4pt;span stylefont-family: Calibri,sans-serif; mso-ascii-theme-font: minor-latin; mso-fareast-font-family: Times New Roman; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; color: black;Highlights of Business Today 8supthsup June 2025 issue:spanp p classMsoNormal styleline-height: 136;span stylefont-family: Calibri,sans-serif; mso-ascii-theme-font: minor-latin; mso-fareast-font-family: Times New Roman; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; color: black; spanp p classMsoNormal styleline-height: 136;span stylefont-family: Calibri,sans-serif; mso-ascii-theme-font: minor-latin; mso-fareast-font-family: Times New Roman; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; color: black;India’s post-pandemic pharma pivot takes centre stage in this issue of Business Today. The June 8 cover story dives into the transformation of Serum Institute of India SII—once the worlds leading Covid vaccine supplier, now innovating its way forward. spanp p classMsoNormal styleline-height: 136;span stylefont-family: Calibri,sans-serif; mso-ascii-theme-font: minor-latin; mso-fareast-font-family: Times New Roman; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; color: black;The June 8 cover feature offers an in-depth analysis of the strategic transformation underway at Serum Institute of India SII. Once the world’s foremost supplier of Covid-19 vaccines, SII, under the leadership of Adar Poonawalla, is recalibrating its operational focus toward a future anchored in research-intensive vaccine innovation, global market penetration, and diversified sectoral investments.spanp p classMsoNormal styleline-height: 136;span stylefont-family: Calibri,sans-serif; mso-ascii-theme-font: minor-latin; mso-fareast-font-family: Times New Roman; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; color: black;As pandemic-driven revenues normalize, SII is charting a renewed trajectory through the development of India’s first indigenous HPV vaccine and ambitions to secure regulatory approvals in the US and EU markets. Parallelly, the group’s pivot into non-core verticals spans diagnostics, financial services via Poonawalla Fincorp, and an unexpected equity stake in film production giant Dharma Productions, underscoring a bold diversification strategy.spanp p classMsoNormal styleline-height: 136;span stylefont-family: Calibri,sans-serif; mso-ascii-theme-font: minor-latin; mso-fareast-font-family: Times New Roman; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; color: black;Also in focus are the broader industry landscape amid the waning relevance of pandemic-era high performers and a sharp editorial reflection on Pakistan’s economic freefall and its militarised roots. spanp p classMsoNormal styleline-height: 136;span stylefont-family: Calibri,sans-serif; mso-ascii-theme-font: minor-latin; mso-fareast-font-family: Times New Roman; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; color: black;This issue encapsulates the dual themes of corporate reinvention and geopolitical reckoning—two sides of a global post-crisis reset.spanp p classMsoNormal styleline-height: 136;span stylefont-family: Calibri,sans-serif; mso-ascii-theme-font: minor-latin; mso-fareast-font-family: Times New Roman; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; color: black;All this and more in the latest issue of BT Magazine. Out on stands now!spanp